Navigation Links
Sally Hed Named President, Chief Manager of ImmunoChemistry Technologies
Date:6/2/2016

ImmunoChemistry Technologies (ICT), a Twin Cities-based biotechnology company that has developed proprietary research and life science tools, has named Sally Hed president and chief manager, effective immediately.

Hed has been with the company for 20 years, most recently as V.P. of marketing and sales. Her first role with the company was as a scientist when it was in its start-up phase. Over the next 20 years, she helped develop products and build the company into the profitable business it is today, with double-digit growth, a solid customer base and an international distributor network serving labs all over the world.

As chief manager, Hed will set the strategic direction of the company as well as oversee all of ICT’s day-to-day operations.

ICT develops tools and technologies that enable biomedical researchers to discover new drugs and treatments for cancer and other diseases affecting both animals and humans. ICT is considered a leading supplier of apoptosis detection kits, which help researchers detect apoptosis or programmed cell death in living laboratory cells. ICT also offers diluent and buffer components for ELISA kit development along with consulting services to assist researchers with their own assay development projects. ICT’s products have been cited in over 1,500 scientific publications.

In 2014, the company sold its proprietary and patented FLIVO® technology to a private equity firm. This technology enables the timely assessment of chemotherapy effectiveness in living animals, which may one day revolutionize cancer treatment.

Now solely woman-owned, all of ICT’s current employees are also female, from PhD-level R&D scientists to college interns. “ICT recruits the best and brightest, regardless of gender, but it's great to be around other women who share a passion for science," Hed said.

“I’ve always been interested in biology and seek to understand how cells differentiate into specific tissue types, reproduce, and die. I believe my contributions to ICT and the researchers who use ICT’s products have had a bigger impact on human health than if I had pursued a clinical career.”

Hed earned a bachelor’s degree in genetics and cell biology from the University of Minnesota in 1991 and an MBA from Cardinal Stritch University in 1999.

Hed is taking over the leadership role at ICT after the retirement of its founding partner and president, Brian W. Lee, Ph.D. Dr. Lee and his wife Carol Lee recently sold their interests in ICT to Hed.

Since founding the company in 1994, Dr. Lee served as ICT’s chief executive as well as product developer and lead scientist for assay development. He developed many of ICT’s research products, including its ELISA buffers, caspase detection reagents, FLICA® apoptosis detection kits, and FLIVO® patent. Dr. Lee will assist with the leadership transition and will continue to mentor ICT’s scientific and technical staff.

“Brian’s serious, yet laid-back attitude made ICT’s lab a stimulating and fun place to work,” Hed said. “We are grateful for his scientific and entrepreneurial contributions that helped build ICT to where it is today.”

ICT’s customers include many established and published biomedical research scientists at pharmaceutical companies and leading universities like Harvard, Yale, Vanderbilt, and the University of Minnesota, as well as cancer research centers such as Fred Hutchinson Cancer Research Center, Moffitt Cancer Center, MD Anderson Cancer Center, and research institutions such as the NIH, Howard Hughes Medical Institute, and the Karolinska Institute.

Read the full story at http://www.prweb.com/releases/2016/06/prweb13458022.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related biology technology :

1. Human Longevity, Inc. Hires Sally A. Howard as Head of Regulatory Affairs and Policy
2. Mucosis Announces Publication of Data Demonstrating Safety and Protection by Mucosally Administered Mimopath®-based Prefusion-like F RSV Vaccines
3. Charles W. Stellar Named WEDI President and CEO
4. Software Provider iLab Solutions Named 25th Fastest Growing Company by Boston Business Journal
5. Cambridge Semantics Named to List of 20 Fastest-Growing Big Data Companies of 2016
6. U.S. Bionic Knee and Ankle Prosthesis Pioneer Hugh Herr Named European Inventor Award 2016 Finalist
7. Becky Butler Cap Named Chief Operating Officer of San Antonio-based GenCure: New Executive to Lead Regenerative Medicine Subsidiary of BioBridge Global
8. Parallel 6 Named One of the 2016 Top 10 eClinical Trial Management Solution Providers by Pharma Tech Outlook Magazine
9. Noblis Named as 2016 Finalist for SECAF’S Small Business Partner of the Year Award
10. Benchmark Research Named Best Clinical Trial Site at VIE Awards
11. Smartlogic named to KMWorld’s 100 Companies that Matter in Knowledge Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... May 25, 2017 , ... Throughout this webinar, participants will ... process development and economic goals were achieved in both industry and academic settings. ... system, along with techniques for scaling production of mesenchymal stem cells (MSCs) and ...
(Date:5/24/2017)... BOUNTIFUL, Utah (PRWEB) , ... May 24, 2017 ... ... announces the selection and implementation of CLEARAS Water Recovery’s Advanced Biological Nutrient Recovery ... a key component of a $24 million plant upgrade to sustainably meet current ...
(Date:5/24/2017)... May 23, 2017 As Ebola resurfaces in the ... deaths and 20 suspected cases now reported, a new analysis ... database, showed a correlation between the 2014 and 2017 outbreaks ... rose sharply in 2012-13, which preceded the 2014 outbreak. An ... Ebola gene Replikin counts in 2014-15, which again precedes the ...
(Date:5/23/2017)... ... May 23, 2017 , ... Genedata, a ... anniversary, marking the occasion with a strong presence at Bio-IT World Conference & ... further extends an invitation to all attendees to view posters on the ...
Breaking Biology Technology:
(Date:4/5/2017)... 2017  The Allen Institute for Cell Science today ... one-of-a-kind portal and dynamic digital window into the human ... first application of deep learning to create predictive models ... and a growing suite of powerful tools. The Allen ... future publicly available resources created and shared by the ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
(Date:3/29/2017)... 2017  higi, the health IT company that operates ... America , today announced a Series B investment ... EveryMove. The new investment and acquisition accelerates higi,s strategy ... transform population health activities through the collection and workflow ... higi collects and secures data today on behalf of ...
Breaking Biology News(10 mins):